[{"indications": "Indications\u00a0see under preparations", "name": "TESTOSTERONE AND ESTERS Oral", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.4 Sex hormones", "6.4.2 Male sex hormones and antagonists", "TESTOSTERONE AND ESTERS", "Oral"], "cautions": "Cautions\u00a0cardiac impairment, elderly, ischaemic heart\r\ndisease, hypertension, epilepsy, migraine, diabetes mellitus, skeletal metastases\r\n(risk of hypercalcaemia), undertake regular examination\r\nof the prostate and breast during treatment; monitor\r\nfull blood count, lipid profile and liver function; pre-pubertal boys (\n(From 6.4.2 Male sex hormones and antagonists: British National Formulary)\nCaution should be used when androgens or chorionic gonadotrophin are used in treating boys with delayed puberty since the fusion of epiphyses is hastened and may result in short stature; skeletal maturation should be monitored. and under Side-effects); interactions: Appendix 1 (testosterone)Women\u00a0Regularly assess for androgenic side-effects; women should be advised to report any signs of virilisation e.g.\r\ndeepening of the voice or hirsutism", "side-effects": "Side-effects\u00a0prostate abnormalities and prostate cancer, headache,\r\ndepression, gastro-intestinal bleeding, nausea, vomiting, cholestatic\r\njaundice, changes in libido, gynaecomastia, polycythaemia, anxiety,\r\nirritability, nervousness, asthenia, paraesthesia, hypertension, electrolyte\r\ndisturbances including sodium retention with oedema and hypercalcaemia,\r\nweight gain; increased bone growth, muscle cramps, arthralgia; androgenic\r\neffects such as hirsutism, male-pattern baldness, seborrhoea, acne,\r\npruritus, excessive frequency and duration of penile erection, precocious\r\nsexual development and premature closure of epiphyses in pre-pubertal\r\nmales, suppression of spermatogenesis in men and virilism in women; rarely liver tumours; sleep apnoea also reported; with patches, buccal tablets, and gel, local irritation and allergic reactions (including\r\nburn-like lesions with patches), and taste disturbances", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4363.htm", "doses": ["See under preparations", "Name[Restandol\u00ae Testocaps (Organon) ] Capsules, orange, testosterone undecanoate\r\n40\u00a0mg in oily solution, net price 30-cap pack = \u00a38.55; 60-cap pack\r\n= \u00a317.10. \r\n    Label:\r\n    21, 25Dose\u00a0androgen deficiency, 120\u2013160\u00a0mg daily for 2\u20133 weeks; maintenance\r\n40\u2013120\u00a0mg daily"], "pregnancy": "Pregnancy\u00a0avoid; causes masculinisation of female fetus"}, {"indications": "Indications\u00a0see under preparations", "name": "TESTOSTERONE AND ESTERS Transdermal preparations", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.4 Sex hormones", "6.4.2 Male sex hormones and antagonists", "TESTOSTERONE AND ESTERS", "Transdermal preparations"], "cautions": "Cautions\u00a0cardiac impairment, elderly, ischaemic heart\r\ndisease, hypertension, epilepsy, migraine, diabetes mellitus, skeletal metastases\r\n(risk of hypercalcaemia), undertake regular examination\r\nof the prostate and breast during treatment; monitor\r\nfull blood count, lipid profile and liver function; pre-pubertal boys (\n(From 6.4.2 Male sex hormones and antagonists: British National Formulary)\nCaution should be used when androgens or chorionic gonadotrophin are used in treating boys with delayed puberty since the fusion of epiphyses is hastened and may result in short stature; skeletal maturation should be monitored. and under Side-effects); interactions: Appendix 1 (testosterone)Women\u00a0Regularly assess for androgenic side-effects; women should be advised to report any signs of virilisation e.g.\r\ndeepening of the voice or hirsutism", "side-effects": "Side-effects\u00a0prostate abnormalities and prostate cancer, headache,\r\ndepression, gastro-intestinal bleeding, nausea, vomiting, cholestatic\r\njaundice, changes in libido, gynaecomastia, polycythaemia, anxiety,\r\nirritability, nervousness, asthenia, paraesthesia, hypertension, electrolyte\r\ndisturbances including sodium retention with oedema and hypercalcaemia,\r\nweight gain; increased bone growth, muscle cramps, arthralgia; androgenic\r\neffects such as hirsutism, male-pattern baldness, seborrhoea, acne,\r\npruritus, excessive frequency and duration of penile erection, precocious\r\nsexual development and premature closure of epiphyses in pre-pubertal\r\nmales, suppression of spermatogenesis in men and virilism in women; rarely liver tumours; sleep apnoea also reported; with patches, buccal tablets, and gel, local irritation and allergic reactions (including\r\nburn-like lesions with patches), and taste disturbances", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/200060.htm", "doses": ["See under preparations", "Apply gel on clean, dry, intact skin\r\nof abdomen or both inner thighs, preferably in the morning. Gently\r\nrub in with a finger until dry before dressing. Wash hands with soap\r\nand water after applying gel; avoid washing application site for at\r\nleast 2 hours. Not to be applied on genital area.", "Name[Tostran\u00ae (ProStrakan) ] Gel, testosterone 2% (10\u00a0mg/metered\r\napplication), net price 60-g multidose dispenser = \u00a326.67. Counselling,\r\nadministration Excipients  include butylhydroxytoluene, propylene glycol (see section 13.1.3)Dose\u00a0hypogonadism due to testosterone deficiency in men (over\r\n18 years), initially 60\u00a0mg testosterone (3\u00a0g gel) applied once daily;\r\nsubsequent applications adjusted according to response; max. 80\u00a0mg\r\n(4\u00a0g gel) dailyCounselling\u00a0Apply gel on clean, dry, intact skin\r\nof abdomen or both inner thighs, preferably in the morning. Gently\r\nrub in with a finger until dry before dressing. Wash hands with soap\r\nand water after applying gel; avoid washing application site for at\r\nleast 2 hours. Not to be applied on genital area.Avoid skin contact with gel application sites to prevent testosterone\r\ntransfer to other people, especially pregnant women and children\u2014consult\r\nproduct literature"], "pregnancy": "Pregnancy\u00a0avoid; causes masculinisation of female fetus"}, {"indications": "Indications\u00a0see under preparations", "name": "TESTOSTERONE AND ESTERS Implant", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.4 Sex hormones", "6.4.2 Male sex hormones and antagonists", "TESTOSTERONE AND ESTERS", "Implant"], "cautions": "Cautions\u00a0cardiac impairment, elderly, ischaemic heart\r\ndisease, hypertension, epilepsy, migraine, diabetes mellitus, skeletal metastases\r\n(risk of hypercalcaemia), undertake regular examination\r\nof the prostate and breast during treatment; monitor\r\nfull blood count, lipid profile and liver function; pre-pubertal boys (\n(From 6.4.2 Male sex hormones and antagonists: British National Formulary)\nCaution should be used when androgens or chorionic gonadotrophin are used in treating boys with delayed puberty since the fusion of epiphyses is hastened and may result in short stature; skeletal maturation should be monitored. and under Side-effects); interactions: Appendix 1 (testosterone)Women\u00a0Regularly assess for androgenic side-effects; women should be advised to report any signs of virilisation e.g.\r\ndeepening of the voice or hirsutism", "side-effects": "Side-effects\u00a0prostate abnormalities and prostate cancer, headache,\r\ndepression, gastro-intestinal bleeding, nausea, vomiting, cholestatic\r\njaundice, changes in libido, gynaecomastia, polycythaemia, anxiety,\r\nirritability, nervousness, asthenia, paraesthesia, hypertension, electrolyte\r\ndisturbances including sodium retention with oedema and hypercalcaemia,\r\nweight gain; increased bone growth, muscle cramps, arthralgia; androgenic\r\neffects such as hirsutism, male-pattern baldness, seborrhoea, acne,\r\npruritus, excessive frequency and duration of penile erection, precocious\r\nsexual development and premature closure of epiphyses in pre-pubertal\r\nmales, suppression of spermatogenesis in men and virilism in women; rarely liver tumours; sleep apnoea also reported; with patches, buccal tablets, and gel, local irritation and allergic reactions (including\r\nburn-like lesions with patches), and taste disturbances", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4370.htm", "doses": ["See under preparations", "Name[Testosterone (Organon) ] Implant, testosterone 100\u00a0mg, net\r\nprice = \u00a37.40; 200\u00a0mg = \u00a313.79Dose\u00a0by implantation, male hypogonadism, 100\u2013600\u00a0mg;\r\n600\u00a0mg usually maintains plasma-testosterone concentration within\r\nthe normal range for 4\u20135 months"], "pregnancy": "Pregnancy\u00a0avoid; causes masculinisation of female fetus"}, {"indications": "Indications\u00a0see under preparations", "name": "TESTOSTERONE AND ESTERS Intramuscular", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.4 Sex hormones", "6.4.2 Male sex hormones and antagonists", "TESTOSTERONE AND ESTERS", "Intramuscular"], "cautions": "Cautions\u00a0cardiac impairment, elderly, ischaemic heart\r\ndisease, hypertension, epilepsy, migraine, diabetes mellitus, skeletal metastases\r\n(risk of hypercalcaemia), undertake regular examination\r\nof the prostate and breast during treatment; monitor\r\nfull blood count, lipid profile and liver function; pre-pubertal boys (\n(From 6.4.2 Male sex hormones and antagonists: British National Formulary)\nCaution should be used when androgens or chorionic gonadotrophin are used in treating boys with delayed puberty since the fusion of epiphyses is hastened and may result in short stature; skeletal maturation should be monitored. and under Side-effects); interactions: Appendix 1 (testosterone)Women\u00a0Regularly assess for androgenic side-effects; women should be advised to report any signs of virilisation e.g.\r\ndeepening of the voice or hirsutism", "side-effects": "Side-effects\u00a0prostate abnormalities and prostate cancer, headache,\r\ndepression, gastro-intestinal bleeding, nausea, vomiting, cholestatic\r\njaundice, changes in libido, gynaecomastia, polycythaemia, anxiety,\r\nirritability, nervousness, asthenia, paraesthesia, hypertension, electrolyte\r\ndisturbances including sodium retention with oedema and hypercalcaemia,\r\nweight gain; increased bone growth, muscle cramps, arthralgia; androgenic\r\neffects such as hirsutism, male-pattern baldness, seborrhoea, acne,\r\npruritus, excessive frequency and duration of penile erection, precocious\r\nsexual development and premature closure of epiphyses in pre-pubertal\r\nmales, suppression of spermatogenesis in men and virilism in women; rarely liver tumours; sleep apnoea also reported; with patches, buccal tablets, and gel, local irritation and allergic reactions (including\r\nburn-like lesions with patches), and taste disturbances", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4368.htm", "doses": ["See under preparations", "Name[Virormone\u00ae (Nordic) ] Injection, testosterone propionate\r\n50\u00a0mg/mL, net price 2-mL amp = \u00a34.50Dose\u00a0by intramuscular injection, androgen deficiency,\r\n50\u00a0mg 2\u20133 times weeklyDelayed puberty, 50\u00a0mg weeklyBreast cancer in women, 100\u00a0mg 2\u20133 times weekly"], "pregnancy": "Pregnancy\u00a0avoid; causes masculinisation of female fetus"}, {"indications": "Indications\u00a0see under preparations", "name": "TESTOSTERONE AND ESTERS Buccal", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.4 Sex hormones", "6.4.2 Male sex hormones and antagonists", "TESTOSTERONE AND ESTERS", "Buccal"], "cautions": "Cautions\u00a0cardiac impairment, elderly, ischaemic heart\r\ndisease, hypertension, epilepsy, migraine, diabetes mellitus, skeletal metastases\r\n(risk of hypercalcaemia), undertake regular examination\r\nof the prostate and breast during treatment; monitor\r\nfull blood count, lipid profile and liver function; pre-pubertal boys (\n(From 6.4.2 Male sex hormones and antagonists: British National Formulary)\nCaution should be used when androgens or chorionic gonadotrophin are used in treating boys with delayed puberty since the fusion of epiphyses is hastened and may result in short stature; skeletal maturation should be monitored. and under Side-effects); interactions: Appendix 1 (testosterone)Women\u00a0Regularly assess for androgenic side-effects; women should be advised to report any signs of virilisation e.g.\r\ndeepening of the voice or hirsutism", "side-effects": "Side-effects\u00a0prostate abnormalities and prostate cancer, headache,\r\ndepression, gastro-intestinal bleeding, nausea, vomiting, cholestatic\r\njaundice, changes in libido, gynaecomastia, polycythaemia, anxiety,\r\nirritability, nervousness, asthenia, paraesthesia, hypertension, electrolyte\r\ndisturbances including sodium retention with oedema and hypercalcaemia,\r\nweight gain; increased bone growth, muscle cramps, arthralgia; androgenic\r\neffects such as hirsutism, male-pattern baldness, seborrhoea, acne,\r\npruritus, excessive frequency and duration of penile erection, precocious\r\nsexual development and premature closure of epiphyses in pre-pubertal\r\nmales, suppression of spermatogenesis in men and virilism in women; rarely liver tumours; sleep apnoea also reported; with patches, buccal tablets, and gel, local irritation and allergic reactions (including\r\nburn-like lesions with patches), and taste disturbances", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/128340.htm", "doses": ["See under preparations", "Name[Striant\u00ae SR (The Urology Co. ) ] Mucoadhesive buccal tablets, m/r,\r\ntestosterone 30\u00a0mg, net price 60-tab pack = \u00a328.00. \r\n    Label:\r\n    Counselling, see under Dose belowDose\u00a0hypogonadism, 30\u00a0mg every 12 hours; child and adolescent under 18 years not\r\nrecommendedCounselling\u00a0Place rounded side of tablet on gum\r\nabove front teeth and hold lip firmly over the gum for 30 seconds.\r\nIf tablet detaches within 4 hours of next dose, replace with new tablet\r\nwhich is considered the second dose for the day."], "pregnancy": "Pregnancy\u00a0avoid; causes masculinisation of female fetus"}, {"indications": "Indications\u00a0see under preparations", "name": "TESTOSTERONE AND ESTERS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.4 Sex hormones", "6.4.2 Male sex hormones and antagonists", "TESTOSTERONE AND ESTERS"], "cautions": "Cautions\u00a0cardiac impairment, elderly, ischaemic heart\r\ndisease, hypertension, epilepsy, migraine, diabetes mellitus, skeletal metastases\r\n(risk of hypercalcaemia), undertake regular examination\r\nof the prostate and breast during treatment; monitor\r\nfull blood count, lipid profile and liver function; pre-pubertal boys (\n(From 6.4.2 Male sex hormones and antagonists: British National Formulary)\nCaution should be used when androgens or chorionic gonadotrophin are used in treating boys with delayed puberty since the fusion of epiphyses is hastened and may result in short stature; skeletal maturation should be monitored. and under Side-effects); interactions: Appendix 1 (testosterone)Women\u00a0Regularly assess for androgenic side-effects; women should be advised to report any signs of virilisation e.g.\r\ndeepening of the voice or hirsutism", "side-effects": "Side-effects\u00a0prostate abnormalities and prostate cancer, headache,\r\ndepression, gastro-intestinal bleeding, nausea, vomiting, cholestatic\r\njaundice, changes in libido, gynaecomastia, polycythaemia, anxiety,\r\nirritability, nervousness, asthenia, paraesthesia, hypertension, electrolyte\r\ndisturbances including sodium retention with oedema and hypercalcaemia,\r\nweight gain; increased bone growth, muscle cramps, arthralgia; androgenic\r\neffects such as hirsutism, male-pattern baldness, seborrhoea, acne,\r\npruritus, excessive frequency and duration of penile erection, precocious\r\nsexual development and premature closure of epiphyses in pre-pubertal\r\nmales, suppression of spermatogenesis in men and virilism in women; rarely liver tumours; sleep apnoea also reported; with patches, buccal tablets, and gel, local irritation and allergic reactions (including\r\nburn-like lesions with patches), and taste disturbances", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4364.htm", "doses": ["See under preparations"], "pregnancy": "Pregnancy\u00a0avoid; causes masculinisation of female fetus"}]